Heart MRI study in adults with type 2 diabetes
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study uses a heart scan (MRI) to learn more about how the heart is affected in people with type 2 diabetes. It may help researchers better understand changes in the heart over time and who might benefit from future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are able to understand the study and give informed consent
- You are between 18 and 80 years old
- You have type 2 diabetes, diagnosed at least 3 months ago
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for early, “silent” changes in heart function in adults with type 2 diabetes, even if you feel okay. It uses heart scans and looks for factors that may help explain why these changes happen.
This study looks at how the heart uses energy fuel in people with heart failure, including those with type 2 diabetes. It may help researchers understand what’s going on inside the heart and how it could be treated in the future.
This study looks at how newly diagnosed type 2 diabetes affects heart and blood vessel health. Researchers will follow patients over time to understand the relationship between diabetes and cardiovascular risk.
This study uses medical scans (MRI) to better understand diabetes in the body, including the eyes, and how it may change over time. It may help improve how diabetes is monitored, especially for people with diabetic eye disease.
This trial uses a low-dose CT scan of the heart’s arteries to measure coronary artery calcification in people with type 2 diabetes. It aims to better understand heart calcium buildup and may help improve risk assessment for people with diabetes.
This study uses a special type of MRI to look at how your heart and brain use energy, in people with type 2 diabetes. It aims to understand the effects of a common diabetes drug called semaglutide, which could help guide better treatment.
Hear when a new Diabetic Cardiomyopathies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.